Correlation Between ACCSYS TECHPLC and BridgeBio Pharma,

Can any of the company-specific risk be diversified away by investing in both ACCSYS TECHPLC and BridgeBio Pharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACCSYS TECHPLC and BridgeBio Pharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ACCSYS TECHPLC EO and BridgeBio Pharma,, you can compare the effects of market volatilities on ACCSYS TECHPLC and BridgeBio Pharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACCSYS TECHPLC with a short position of BridgeBio Pharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACCSYS TECHPLC and BridgeBio Pharma,.

Diversification Opportunities for ACCSYS TECHPLC and BridgeBio Pharma,

0.65

Correlation Coefficient

ACCSYS TECHPLC  BridgeBio Pharma,

Poor diversification

The 3 months correlation between ACCSYS and BridgeBio is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding ACCSYS TECHPLC EO and BridgeBio Pharma, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma, and ACCSYS TECHPLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACCSYS TECHPLC EO are associated (or correlated) with BridgeBio Pharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma, has no effect on the direction of ACCSYS TECHPLC i.e., ACCSYS TECHPLC and BridgeBio Pharma, go up and down completely randomly.

Pair Corralation between ACCSYS TECHPLC and BridgeBio Pharma,

Assuming the 90 days horizon ACCSYS TECHPLC EO is expected to generate 1.43 times more return on investment than BridgeBio Pharma,. However, ACCSYS TECHPLC is 1.43 times more volatile than BridgeBio Pharma,. It trades about 0.14 of its potential returns per unit of risk. BridgeBio Pharma, is currently generating about 0.17 per unit of risk. If you would invest  50.00  in ACCSYS TECHPLC EO on April 24, 2025 and sell it today you would earn a total of  16.00  from holding ACCSYS TECHPLC EO or generate 32.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

ACCSYS TECHPLC EO  vs.  BridgeBio Pharma,

ACCSYS TECHPLC EO

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in ACCSYS TECHPLC EO are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ACCSYS TECHPLC reported solid returns over the last few months and may actually be approaching a breakup point.

BridgeBio Pharma,

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in BridgeBio Pharma, are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BridgeBio Pharma, reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ACCSYS TECHPLC and BridgeBio Pharma,

The main advantage of trading using opposite ACCSYS TECHPLC and BridgeBio Pharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACCSYS TECHPLC position performs unexpectedly, BridgeBio Pharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma, will offset losses from the drop in BridgeBio Pharma,'s long position.

The idea behind ACCSYS TECHPLC EO and BridgeBio Pharma, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.